Skip to main content
All lobbying filings

WILLIAMS AND JENSEN, PLLC

Lobbying for ACCENDRA HEALTH, INC. (FORMERLY "OWENS & MINOR, INC.") · Health care logistics, PPE distribution and manufacturing

 Filing 2nd Quarter - Report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$80,000.00
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Lobbyists on this filing 4
  • LAURA M SIMMONS New on this filing
    Previously held: Advisor, Office of Legislative Affairs, Dept of Homeland Security
  • ROBERT BUTORA New on this filing
    Previously held: Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess
  • JEANNE HAGGERTY New on this filing
    Previously held: Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member
  • CHRISTOPHER E. WILCOX
    Previously held: LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 4
  • Centers For Medicare and Medicaid Services (CMS)
  • Health & Human Services, Dept of (HHS)
  • HOUSE OF REPRESENTATIVES
  • SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 6
 Lobbying activity 4
Taxation/Internal Revenue Code

Specific issues "monitoring and reporting on reconciliation legislation"; implementation of PL 119-21.

Health Issues

Issues related to patient access to home medical equipment and related reimbursement.

Medicare/Medicaid

Issues related to access to home medical equipment and related reimbursement (i.e., "Diabetes Interventions Addressing Barriers to Enrollment, Technology, and Education Services [DIABETES] Act" (S. 4037) and "DMEPOS Relief Act of 2025" [H.R. 2005, S. 2951]; and competitive bidding, "Supplemental Oxygen Access Reform [SOAR] Act of 2025" [H.R. 2902, S. 1406]); "DME Scammer Prevention (H.R. 8871)"; promoting electronic prescribing platforms; and diabetes management and related durable medical equipment reimbursement channels.

Budget/Appropriations

FY 2027 Appropriations.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem